Incyte's topical Jakafi scores again in eczema Phase III; Priority review lines Roche's Tecentriq up for new lung cancer nod
→ Incyte’s ruxolitinib cream — topical formulation of the drug that gave them their cash cow Jakafi — has delivered again in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
